Probingon's mission is to provide the enabling communication technology for the next generation of implantable medical devices. We license FAT-IBC, a validated wireless intrabody communication subsystem, to OEM manufacturers, giving them the physical layer required to build distributed therapeutic systems that can sense and respond independently inside the body.
Our commitment is to the integrity of the science, the rigour of the validation, and the partnerships through which the technology reaches patients.
Today's implantable devices are constrained by colocation: sensing and stimulation must happen from the same unit, limiting what therapy can achieve. Our vision is a future where independent implanted devices communicate as coordinated systems inside the body, enabling genuine closed-loop therapy across the full field of bioelectric medicine.
As this communication infrastructure enters the healthcare ecosystem, it also creates new possibilities for clinical wearables and continuous monitoring, contributing to the transition from episodic to preventive and continuous healthcare that European health systems are actively pursuing.